Lindis Biotech Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Lindis Biotech Gmbh

Patent Number:
Title:
Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains
Opposition Date:
Dec 7, 2017

Latest patents of Lindis Biotech Gmbh opposed by its competitors

Patent:
Grant Date:
Feb 17, 2021
Title:
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
Oppositions:
10

Want to track Lindis Biotech Gmbh?

Feel free to send us a message here and we will get back to you